Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Highly potent and selective Y1 receptor antagonists designed at Lilly

April 6, 1999

CRC presents results of R&D in the area of protein prenylation inhibitors at ACS meeting

April 5, 1999

Aurora and Becton Dickinson announce drug development agreement

April 1, 1999

CuraGen and Roche reach drug discovery agreement

March 30, 1999

Iomed to develop drugs to treat local inflammation, ocular disease and pain control

March 29, 1999

Function of anandamide discovered

March 29, 1999

U.S. patent issues for Genzyme's pseudo-adenoviral vectors

March 25, 1999

Patent issued to GenVec covering gene delivery systems targeting specific tissues

March 24, 1999

Ariad receives broader patent coverage for its ARGENT and Dimerizer Drugs technologies

March 24, 1999

Genetronics receives CE Mark approval for MedPulser solid tumor treatment

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...